tiprankstipranks
Advertisement
Advertisement
Underperform Reiterated on Ardent: Aggressive EBITDA Targets and Reimbursement Risks Undermine Valuation
PremiumRatingsUnderperform Reiterated on Ardent: Aggressive EBITDA Targets and Reimbursement Risks Undermine Valuation
23d ago
Ardent Health reports Q4 EPS 32c, consensus 35c
Premium
The Fly
Ardent Health reports Q4 EPS 32c, consensus 35c
23d ago
Ardent Health sees FY26 EPS $0.90-$1.27, consensus $1.35
Premium
The Fly
Ardent Health sees FY26 EPS $0.90-$1.27, consensus $1.35
23d ago
Ardent Health price target lowered to $14 from $14.50 at UBS
PremiumThe FlyArdent Health price target lowered to $14 from $14.50 at UBS
3M ago
Ardent Health price target lowered to $12 from $20 at Mizuho
Premium
The Fly
Ardent Health price target lowered to $12 from $20 at Mizuho
3M ago
Ardent Health price target lowered to $12 from $15 at JPMorgan
Premium
The Fly
Ardent Health price target lowered to $12 from $15 at JPMorgan
4M ago
Ardent Health price target lowered to $14.50 from $17 at UBS
PremiumThe FlyArdent Health price target lowered to $14.50 from $17 at UBS
4M ago
Block upgraded, Dell downgraded: Wall Street’s top analyst calls
Premium
The Fly
Block upgraded, Dell downgraded: Wall Street’s top analyst calls
4M ago
Ardent Health downgraded to Sector Weight from Overweight at KeyBanc
Premium
The Fly
Ardent Health downgraded to Sector Weight from Overweight at KeyBanc
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100